ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 117274 Null 0.00970780973624031 0.16898126
NSC 119875 Cisplatin 0.00970780973624031 0.64565709
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00970780973624031 0.66236926
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00970780973624031 0.49910964
NSC 681643 Camptothecin Derivative 0.00970780973624031 0.86699479
NSC 681646 Camptothecin Derivative 0.00970780973624031 0.9257046
NSC 688812 Null 0.00970780973624031 0.0081200696
NSC 720447 Null 0.00970780973624031 -0.098579891
NSC 740 Methotrexate 0.00970780973624031 0.60974885
NSC 145668 Cyclocytidine hydrochloride 0.0100995289754787 0.65786385
Total:64  Current:13    [First] [Prev] [Next] [Last]